HYDROCORTISONE SODIUM PHOSPHATE
( DrugBank: Hydrocortisone, Hydrocortisone sodium phosphate / KEGG DRUG: Hydrocortisone, Hydrocortisone sodium phosphate )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 53 | Sjogren syndrome | 1 |
| 81 | Congenital adrenal hyperplasia | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 83 | Addison disease | 1 |
53. Sjogren syndrome
Clinical trials : 448 / Drugs : 436 - (DrugBank : 104) / Drug target genes : 68 - Drug target pathways : 185
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
81. Congenital adrenal hyperplasia
Clinical trials : 107 / Drugs : 101 - (DrugBank : 24) / Drug target genes : 14 - Drug target pathways : 71
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
83. Addison disease
Clinical trials : 23 / Drugs : 42 - (DrugBank : 11) / Drug target genes : 3 - Drug target pathways : 7
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|